After finishing at $14.75 in the prior trading day, Adverum Biotechnologies Inc (NASDAQ: ADVM) closed at $16.06, up 8.88%. In other words, the price has increased by $+1.31 from its previous closing price. On the day, 576550 shares were traded. ADVM stock price reached its highest trading level at $16.48 during the session, while it also had its lowest trading level at $14.00.
Ratios:
Our goal is to gain a better understanding of ADVM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.13 and its Current Ratio is at 4.13. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.77.
SVB Leerink Downgraded its Outperform to Mkt Perform on May 03, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 07 ’24 when Lupher, Jr. Mark L. bought 130,000 shares for $1.35 per share. The transaction valued at 175,500 led to the insider holds 130,000 shares of the business.
Scopa James Paul bought 100,000 shares of ADVM for $135,000 on Feb 07 ’24. The Director now owns 100,000 shares after completing the transaction at $1.35 per share. On Sep 15 ’23, another insider, Seyedkazemi Setareh, who serves as the Chief Development Officer of the company, sold 6,201 shares for $1.52 each. As a result, the insider received 9,429 and left with 47,674 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADVM now has a Market Capitalization of 333.32M and an Enterprise Value of 311.83M. For the stock, the TTM Price-to-Sale (P/S) ratio is 92.57 while its Price-to-Book (P/B) ratio in mrq is 1.95. Its current Enterprise Value per Revenue stands at 86.62 whereas that against EBITDA is -2.63.
Stock Price History:
Over the past 52 weeks, ADVM has reached a high of $29.70, while it has fallen to a 52-week low of $6.81. The 50-Day Moving Average of the stock is 16.41, while the 200-Day Moving Average is calculated to be 14.07.
Shares Statistics:
The stock has traded on average 223.41K shares per day over the past 3-months and 294.43k shares per day over the last 10 days, according to various share statistics. A total of 20.75M shares are outstanding, with a floating share count of 14.97M. Insiders hold about 27.90% of the company’s shares, while institutions hold 33.27% stake in the company. Shares short for ADVM as of Feb 29, 2024 were 542.55k with a Short Ratio of 2.43, compared to 122.28k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.26% and a Short% of Float of 0.27%.
Earnings Estimates
Its stock is currently analyzed by 5 different market analysts. On average, analysts expect EPS of -$1.49 for the current quarter, with a high estimate of -$1.2 and a low estimate of -$2.26, while EPS last year was -$2.9. The consensus estimate for the next quarter is -$1.36, with high estimates of -$1.2 and low estimates of -$1.68.
Analysts are recommending an EPS of between -$4.8 and -$9.6 for the fiscal current year, implying an average EPS of -$6.33. EPS for the following year is -$5.97, with 6 analysts recommending between -$4.9 and -$7.
